The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes.
The incidence of drugs in drivers killed in Australian road traffic crashes.
Validation of new methods.
Central sleep apnea in stable methadone maintenance treatment patients.
Thirty percent of stable MMT patients have CSA, a minority of which can be explained by blood methadone concentration, and other physiologic variables may also play a role in the pathogenesis of CSA in M MT patients, and further research is indicated.
Dose related risk of motor vehicle crashes after cannabis use.
Developing limits for driving under cannabis.
This analysis offers an empirical basis for a per se limit for THC that allows identification of drivers impaired by cannabis and suggests a suitable numerical limit may fall in the 7-10 ng/ml range.
Analysis of time of closure of the spheno-occipital synchondrosis using computed tomography.
DRUGS IN DRIVERS KILLED IN AUSTRALIAN ROAD TRAFFIC ACCIDENTS: THE USE OF RESPONSIBILITY ANALYSIS TO INVESTIGATE THE CONTRIBUTION OF DRUGS TO FATAL ACCIDENTS
- O. Drummer
- Political Science
- 1 March 1994
The Forensic Pharmacology of Drugs of Abuse
Section 1 specimens and specimen collection procedures: analysis and measurement pharmacokinetics and duration of action tolerance and dependence toxicology and postmortem artefacts, and mechanisms of action pharmacological actions and therapeutics adverse reaction, tolerance and dependency toxicology case reports.
Drug testing in oral fluid.
- O. Drummer
- Biology, MedicineClinical biochemist reviews
- 1 August 2006
Oral fluid concentrations of basic drugs such as the amphetamines, cocaine and some opioids are similar or higher than those in plasma, and screening techniques are usually an adaptation of those used in other specimens, with an emphasis on the parent drug since this is usually the dominant species present in oral fluid.